Final deliverables and references from Working Groups Projects can be found in this section of the website. Use the filters to narrow down your search.
Show/hide columns
| Year | Working Group | Deliverable Types | Deliverable Format | Title | Status | Links |
|---|---|---|---|---|---|---|
2024 | Data Transparency | Reference | Blog | EU CTR Update: Year 2 | Current | EU+CTR+Update+–+Year+2.pdf |
2024 | Real World Evidence | Reference | Poster | Ensuring Registry Data Relevance and Reliability for Regulatory Use | Current | Ensuring+Registry+Data+Relevance+and+Reliability+for+Regulatory+Use.pdf |
2024 | Special Projects | Reference | White Paper | Data Standards White Paper | Current | WP086.pdf |
2024 | Risk Based Quality Management | Reference | White Paper | Assessing the Use of Quality Tolerance Limits in the Pharmaceutical Industry | Current | WP-084.pdf |
2024 | Data Transparency | Reference | Recording | Data Privacy and Data Sharing in Clinical Trials – What Will I Receive and When Will I Receive It? | Current | https://www.youtube.com/watch?v=cyk2DJuazB8 |
2024 | Real World Evidence | Reference | Blog | Understanding the Data Quality Issues in Real-World Data Through Real-World Examples | Current | https://phuse.global/Communications/PHUSE_Blog/understanding-the-data-quality-issues-in-real-world-data-through-real-world-examples |
2024 | Real World Evidence | Reference | Blog | Considerations for the Use of Real-World Data and Real-World Evidence to Support Regulatory Decision-Making for Drug and Biological Products | Current | https://phuse.global/Communications/PHUSE_Blog/considerations-for-the-use-of-real-world-data-and-real-world-evidence-to-support-regulatory-decision-making-for-drug-and-biological-products |
2023 | Real World Evidence | Reference | White Paper | Requirements and Recommendations for Regulatory Submissions | Current | WP-074.pdf |
2023 | Emerging Trends & Technologies | Reference | Poster | Patient Foundations Guide to Starting a Registry | Current | Patient Foundations Guide to Starting a Registry.pdf |
2023 | Emerging Trends & Technologies | Reference | Poster | Patient Registry Transparency Checklist For Patient Foundations | Current | Patient Registry Transparency Checklist For Patient Foundations.pdf |
2023 | Emerging Trends & Technologies | Reference | Poster | Myths VS Facts About Patient Registries | Current | Myths VS Facts About Patient Registries.pdf |
2023 | Optimizing the Use of Data Standards | Regulatory Referenced Deliverable | Template | BDRG V3.0 Package | Current | BDRG+V3.0+Package.zip |
2023 | Data Visualisation & Open Source Technology | Reference | White Paper | Key Considerations When Understanding Differences in Statistical Methodology Implementations Across Programming Languages – An Introduction to the CAMIS Project | Current | WP077.pdf |
2023 | Optimizing the Use of Data Standards | Regulatory Referenced Deliverable | Template | iADRG | Current | iADRG V1 Package.zip |
2023 | Risk Based Quality Management | Reference | White Paper | Can the Value of Centralised Monitoring Be Quantified? | Current | WP-075.pdfWP-075-Survey-Results.pdf |
2023 | Data Visualisation & Open Source Technology | Reference | White Paper | End-to-End Open-source Collaboration Guidance | Current | https://phuse-org.github.io/E2E-OS-Guidance/using.html |
2023 | Data Visualisation & Open Source Technology | Reference | White Paper | Julia for High-Performance Computing | Current | Julia+for+High-Performance+Computing+White+Paper.pdf |
2023 | Emerging Trends & Technologies | Reference | White Paper | Cloud Framework Pre-Amble | Current | Cloud Framework Pre-Amble.pdf |
2023 | Data Transparency | Reference | Blog | EU CTR Update: Year 1 Blog | Current | https://phuse.global/Communications/PHUSE_Blog/eu-ctr-update-year-1 |
2022 | Special Projects | Reference | White Paper | PHUSE Clinical Data Scientists Guide to Studies Impacted by COVID-19 V2 | Current | WP051.pdf |
